Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.2386
Delayed Data
As of 3:20pm ET
 +0.0136 / +6.04%
Today’s Change
0.20
Today|||52-Week Range
0.64
-32.85%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.21 - 0.24
Volume485,531
Average volume (3 months)281,542
Market cap$19.8M
Dividend yield--
Data as of 3:20pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
HTGMHTG Molecular Diagno...+0.11+3.89%
ABACAoxin Tianli Group I...-0.01-0.89%
--Protea Biosciences G...+0.02+8.33%
OPGNOpGen Inc-0.15-11.18%
Data as of 2:43pm ET, 05/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts

Partner Offers

Search for Jobs